Adicet Bio, Inc. (ACET)
NASDAQ: ACET · IEX Real-Time Price · USD
1.100
-0.050 (-4.35%)
At close: Jul 2, 2024, 4:00 PM
1.090
-0.010 (-0.91%)
After-hours: Jul 2, 2024, 7:36 PM EDT
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
143
Market Cap
90.39M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 24.99M | 15.26M | 156.83% |
Dec 31, 2021 | 9.73M | -8.17M | -45.65% |
Dec 31, 2020 | 17.90M | 16.91M | 1,699.30% |
Dec 31, 2019 | 995.00K | -7.19M | -87.84% |
Dec 31, 2018 | 8.18M | - | - |
Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionACET News
- 4 days ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 8 days ago - Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma - Business Wire
- 27 days ago - Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis - Business Wire
- 4 weeks ago - Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference - Business Wire
- 7 weeks ago - Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates - Business Wire
- 7 weeks ago - Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress - Business Wire
- 2 months ago - Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - Business Wire
- 2 months ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire